Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Cancer treatments often cause skin, nail, and hair problems.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Enhancing immune response can improve cancer treatment effectiveness.

A woman with severe angioedema improved significantly after treatment with rituximab.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Using SVF enriched with PRP in surgery for certain fistulas is effective and safe.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.